Filing Flows › Balchem (BCPC) › Q2 2026
Balchem (BCPC) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Balchem (BCPC) reported revenue of $284M for the second quarter 2026 (Q2 2026), +11% from a year earlier and +5% from the quarter before. Operating margin was 20.9%, net earnings $44.6M (15.7% of revenue).
Balchem, Q2 2026: revenue $284M (+11% year over year), operating margin 20.9%, net earnings $44.6M, operating cash flow $46.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $284M | +5% | +11% |
| Gross profit | $104M | +3% | +11% |
| Operating profit | $59.2M | +6% | +15% |
| Net earnings | $44.6M | +11% | +17% |
| Operating cash flow | $46.7M | +17% | -1% |
| Free cash flow | $36.2M | — | -11% |
What changed
Revenue was $284.0M in Q2 2026, up 11% year over year and up 5% from the previous quarter. Product Sales Revenue was the largest line at 100% of revenue. Product Sales Revenue added $28.3M year over year (up 11%), 99% of the total change.
Gross margin was 36.5%, up 0.1 points from Q2 2025. Operating profit was $59.2M, a 20.9% margin (up 0.7 points year over year). Of the extra revenue versus Q2 2025, 27% reached operating profit, above the 20% margin then. Operating expenses grew 7% against revenue growth of 11%. Net earnings were $44.6M, up 17% year over year. The effective tax rate was 22.8%.
Operating cash flow was $46.7M (down 1% year over year), 105% of net earnings. Non-cash charges added back $12.2M of depreciation and amortization and $5.9M of share-based compensation. Working capital and other items used $16.0M. After capital expenditures and proceeds from the sale of assets ($10.5M), free cash flow as the company reports it was $36.2M.
Questions
What was Balchem's revenue in the second quarter 2026?
Balchem (BCPC) reported revenue of $284M for the second quarter 2026 (Q2 2026), +11% from a year earlier and +5% from the quarter before.
Was Balchem profitable in the second quarter 2026?
Operating profit was $59.2M (20.9% of revenue) and net earnings $44.6M.
Source: Balchem 10-Q on SEC EDGAR.